Feed / A

Agilent Technologies, Inc.

A

Healthcare · 131.43 -3.4% today

In Healthcare Innovation as a Participant.

Jodie monitors A’s market activity, durable peer group membership, and filing-linked connections.

SEC company filingsCIK 0001090872

Latest filing assessment · baseline

Fundamentals strengthened in the latest filing

10-Q filed 2026-06-01 against the comparable filing from 2025-06-02.

constructive
OperationsconstructiveEvidence score +3
liquidityneutralEvidence score 0
valuationmixed

What improved

  • Revenue increased 10.0% versus the comparable filing period.
  • Operating margin improved 3.8 percentage points.
  • Net income increased 57.7% versus the comparable filing period.

What weakened

No thresholded deterioration was identified.

Filing receipts

Gross margin for the six months ended April 30, 2026 was overall favorably impacted by higher sales volume, targeted price increases, lower restructuring expense and lower intangible amortization expense partially offset by higher tariffs, unfavorable business mix (including lower gross margin from our Agilent Advanced Therapeutics business), wage increases and higher variable pay when compared to the same period last year.

Gross margin for the six months ended April 30, 2026 was impacted mainly by higher tariffs, unfavorable business mix (including lower gross margin from our Agilent Advanced Therapeutics business), increased warranty expenses, wage increases and higher variable pay which was partially offset by higher sales volume, price increases and savings from restructuring programs.

Gross margin for the three months ended April 30, 2026 was impacted mainly by higher sales volume, price increases, decreased tariffs, favorable business mix (net of lower gross margin from our Agilent Advanced Therapeutics business) and savings from restructuring programs partially offset by increased warranty expenses, wage increases and higher variable pay.

Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.

Exposure map

Depends on

KEYSKeysight Technologies Inc.supplierPro receipt
AMGNAmgen Inc.investeePro receipt

Depended on by

ALNYAlnylam Pharmaceuticals, Inc.supplierPro receipt

Filing peers

Companies whose filings use similar operating language.

Showing a three-relationship preview; 15 more links and their filing receipts are in Pro. View plans →

Live connections

A is currently in Healthcare Innovation. 3 filing-linked names are shown in the exposure map.

Theme membership history

No durable theme membership has been observed for this name yet.